The Vioxx Recall Tested Our Leadership
Harvard Business Review
OCTOBER 6, 2011
The concern I expressed in the post was that these actions have become the standard by which CEOs are expected to manage. I, along with the rest of my management team and the board, agreed with the recommendation, and the drug was withdrawn. We had done a restructuring in 2001 with a significant number of layoffs.
Let's personalize your content